Understanding Post-SSRI Sexual Dysfunction (PSSD)

Panel discussion with audience Q&A. What do we know about PSSD, and what can be done to protect and support patients?

Post-SSRI Sexual Dysfunction (PSSD) is a serious and often misunderstood condition that, for some, can persist long after stopping antidepressants. It can profoundly affect sexuality, relationships, identity and happiness, and yet PSSD sufferers are often disbelieved or misunderstood by medical professionals, left without guidance and (for many, it can feel) without hope.

However, the topic of PSSD has received increased attention in recent years, with articles in mainstream media such as The Guardian and the New York Times, new warnings on Australia’s antidepressant labels and most recently, acknowledgement by the UK’s MHRA. Researchers in Italy are currently looking at possible biological mechanisms of PSSD, and a global patient advocacy network has raised public awareness through a successful social media campaign. Without doubt, the time has come for a public conversation on Post-SSRI Sexual Dysfunction.

This webinar brings together lived experience voices, clinical insight, research and advocacy perspectives to talk about the topic, offering an overview of PSSD – what it is, why it matters and what can be done to support sufferers and protect patients.

There will be an opportunity during the webinar to ask the panellists your questions.

If you can’t join us live, you’ll receive a link to the recording shortly after the event.